Bio-Techne appreciates the critical role that you and our products and services play in research efforts to further scientific innovation and discovery. We are continually assessing our manufacturing and supplier capabilities during the COVID-19 situation and are implementing precautionary measures to ensure uninterrupted supply of products and services. Currently, and as we abide by local shelter in place orders across the world, we are fully operational and do not anticipate any material supply disruptions across our Bio-Techne brands and product lines. As the situation evolves, our goal is to utilize preventive measures to reduce the threat that COVID-19 poses to our ability to meet the needs of our customers globally.
Bio-Techne
WHERE SCIENCE INTERSECTS INNOVATIONTM
![Western Blot: VEGF R3/Flt-4 Antibody (9D9) [NBP1-18651] - Analysis using recombinant human soluble VEGF Receptor 3 as target.](http://images.novusbio.com/fullsize2/VEGF-R3-Flt-4-Antibody-(9D9)-Western-Blot-NBP1-18651-img0010.jpg "Western Blot: VEGF R3/Flt-4 Antibody (9D9) [NBP1-18651] - Analysis using recombinant human soluble VEGF Receptor 3 as target.")
![Immunocytochemistry/Immunofluorescence: VEGF R3/Flt-4 Antibody (9D9) [NBP1-18651] - Immunofluorescence staining of human VEGFR-3/FLT-4 (red) in immortalized lymphatic endothelial cells (LEC-Tert). Left panel negative control with secondary antibody only; right panel with specific antibody against human FLT-4.](http://images.novusbio.com/fullsize2/VEGF-R3-Flt-4-Antibody-(9D9)-Immunocytochemistry-Immunofluorescence-NBP1-18651-img0009.jpg)
![Flow Cytometry: VEGF R3/Flt-4 Antibody (9D9) [NBP1-18651] - Fig. 1: Flow analysis of VEGFR-3/FLT4 expression in primary human dermal lymphatic endothelial cells (HDLEC).](http://images.novusbio.com/fullsize2/VEGF-R3-Flt-4-Antibody-(9D9)-Flow-Cytometry-NBP1-18651-img0007.jpg)
![Immunocytochemistry/Immunofluorescence: VEGF R3/Flt-4 Antibody (9D9) [NBP1-18651] - Immunofluorescence staining of human VEGFR-3/FLT-4 (red) in hFlt4-transfected MG63 cells. Monoclonal mouse anti-human FLT-4 #9D9 and polyclonal rabbit anti-human FLT-4]: A and C are negative control with secondary antibody only; B and D with specific antibodies against human FLT-4.](http://images.novusbio.com/fullsize2/VEGF-R3-Flt-4-Antibody-(9D9)-Immunocytochemistry-Immunofluorescence-NBP1-18651-img0008.jpg)
![Flow Cytometry: VEGF R3/Flt-4 Antibody (9D9) [NBP1-18651] - Fig. 1: Flow analysis of VEGFR-3/FLT4 expression in primary human dermal mivrovascular endothelial cells (HDMVEC) and human umbilical vein endothelial cells (HUVEC). There is only a very weak expression of VEGFR-3/FLT4 detectable in the HUVECs but a strong one in the HDMVEC.](http://images.novusbio.com/fullsize2/VEGF-R3-Flt-4-Antibody-(9D9)-Flow-Cytometry-NBP1-18651-img0006.jpg)
![Immunohistochemistry-Frozen: VEGFR3/Flt-4 Antibody (AFL4) [NBP1-43259] - VEGFR-3 (green) was detected in murine cancer using VEGFR-3-AlexaFluor488 antibody (1:50; 1 hour) in PBS. Nuclei were stained with DAPI (blue). Tissue was fixed in acetone. Image from a verified customer review using the Alexa Fluor488 version of this VEGFR-3 antibody.](http://images.novusbio.com/fullsize2/VEGFR3-Flt-4 Antibody (AFL4)-Immunohistochemistry-Frozen-NBP1-43259-img0003.jpg "Immunohistochemistry-Frozen: VEGFR3/Flt-4 Antibody (AFL4) [NBP1-43259] - VEGFR-3 (green) was detected in murine cancer using VEGFR-3-AlexaFluor488 antibody (1:50; 1 hour) in PBS. Nuclei were stained with DAPI (blue). Tissue was fixed in acetone. Image from a verified customer review using the Alexa Fluor488 version of this VEGFR-3 antibody.")
![Flow Cytometry: VEGFR3/Flt-4 Antibody (AFL4) [NBP1-43259] - Surface staining of MC/9 cell line with Anti-Mouse Fc epsilon Receptor I alpha (Fc epsilon R1) FITC (left) and PE (right). Appropriate isotype controls were used (open histogram). Total viable cells were used for analysis.](http://images.novusbio.com/fullsize2/VEGFR3-Flt-4-Antibody-(AFL4)-Flow-Cytometry-NBP1-43259-img0002.jpg)
